Home › Endometriosis › NCT03746535

Cardiovascular Disease Risk in Women With Endometriosis

Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis

Who can join

Ages 18 to 45 · Women · Healthy volunteers welcome

Inclusion Criteria:

* Young women between the ages of 18 and 45 years (Controls);
* Young women between the ages of 18 and 45 years with endometriosis.

Exclusion Criteria:

* Subjects who smoke
* Subjects who have diabetes,
* Subjects with sleep apnea or BP\>140/90 will be excluded.
* Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.

About the study

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

What is being tested

• Elagolix (drug)

Sponsor: Yale University · Participants: 40 · Started: Jul 1, 2022

Contact the study team

• Nina Stachenfeld, PhD · Phone: 203-562-9901

Official record on ClinicalTrials.gov — NCT03746535

Locations in the U.S.

Conditions

• Endometriosis

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.